Sox10 and s100 in the diagnosis of soft-tissue neoplasms

Applied Immunohistochemistry and Molecular Morphology

Volumn 20, Issue 5, 2012, Pages 445-450

  Karamchandani, Jason R ^a   Nielsen, Torsten O ^b   Van De Rijn, Matt ^a   West, Robert B ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

MPNST; Neural crest; Peripheral nerve sheath tumors; S100 protein; Schwann cell; Schwannoma; Sox10; Synovial sarcoma

Indexed keywords

MESSENGER RNA; PROTEIN S 100; TRANSCRIPTION FACTOR SOX10;

ARTICLE; CHONDROSARCOMA; CLEAR CELL SARCOMA; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC VALUE; EWING SARCOMA; GENE EXPRESSION PROFILING; GRANULAR CELL TUMOR; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MELANOMA; NERVE TUMOR; NEURAL CREST; NEURILEMOMA; NEUROFIBROMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SARCOMA; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR; SYNOVIAL SARCOMA; TISSUE MICROARRAY; TUMOR DIAGNOSIS;

GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; SOXE TRANSCRIPTION FACTORS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866632232     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318244ff4b     Document Type: Article

References (27)

1. Nakajima T, Watanabe S, Sato Y, et al. S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells. Gann. 1982;73:429-432.
2. Shimada H, Newton WA Jr, Soule EH, et al. Pathologic features of extraosseous Ewing's sarcoma: a report from the Intergroup Rhabdomyosarcoma Study. Hum Pathol. 1988;19:442-453.
3. Coindre JM, de MA, Trojani M, et al. Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S100 protein and cytokeratin. J Pathol. 1988;155:127-132.
4. Fisher C. Synovial sarcoma. Ann Diagn Pathol. 1998;2:401-421.
5. Fisher C, Schofield JB. S-100 protein positive synovial sarcoma. Histopathology. 1991;19:375-377.
6. Paratore C, Goerich DE, Suter U, et al. Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development. 2001;128:3949-3961.
7. Kuhlbrodt K, Herbarth B, Sock E, et al. Sox10, a novel transcriptional modulator in glial cells. J Neurosci. 1998;18:237-250.
8. Kelsh RN. Sorting out Sox10 functions in neural crest development. Bioessays. 2006;28:788-798.
9. Herbarth B, Pingault V, Bondurand N, et al. Mutation of the Sryrelated Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci USA. 1998;95: 5161-5165.
10. Kuhlbrodt K, Schmidt C, Sock E, et al. Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients. J Biol Chem. 1998;273:23033-23038.
11. Osaka H, Hamanoue H, Yamamoto R, et al. Disrupted SOX10 regulation of GJC2 transcription causes Pelizaeus-Merzbacher-like disease. Ann Neurol. 2010;68:250-254.
12. Bondurand N, Girard M, Pingault V, et al. Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie- Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet. 2001;10:2783-2795.
13. Pingault V, Bondurand N, Le CC, et al. The SOX10 transcription factor: evaluation as a candidate gene for central and peripheral hereditary myelin disorders. J Neurol. 2001;248:496-499.
14. Nonaka D, Chiriboga L, Rubin BP. Sox10: a pan-schwannian and melanocytic marker. Am J Surg Pathol. 2008;32:1291-1298.
15. Subramanian S, Thayanithy V, West RB, et al. Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol. 2010;220:58-70.
16. Hubble J, Demeter J, Jin H, et al. Implementation of GenePattern within the Stanford microarray database. Nucleic Acids Res. 2009; 37:D898-D901. (Database issue).
17. Terry J, Saito T, Subramanian S, et al. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol. 2007;31:240-246.
18. Nielsen TO, Hsu FD, O'Connell JX, et al. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol. 2003;163:1449-1456.
19. Weiss SW, Goldblum JR, Enzinger FM. Enzinger and Weiss' Soft Tissue Tumors. 5th ed. Philadelphia, PA: Mosby Elsevier; 2008:872-878.
20. Jagdis A, Rubin BP, Tubbs RR, et al. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma. Am J Surg Pathol. 2009;33:1743-1751.
21. Dabbs DJ. Diagnostic Immunohistochemistry. 2nd ed. Edinburgh: Churchill Livingstone Elsevier; 2006:828.
22. Armin A, Connelly EM, Rowden G. An immunoperoxidase investigation of S-100 protein in granular cell myoblastomas: evidence for Schwann cell derivation. Am J Clin Pathol. 1983;79: 37-44.
23. Scheithauer BW, Woodruff JM, Erlandson RA. Armed Forces Institute of Pathology (U.S.), Universities Associated for Research and Education in Pathology. Tumors of the Peripheral Nervous System.Washington, D.C: Armed Forces Institute of Pathology; 1999.
24. Parmantier E, Lynn B, Lawson D, et al. Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. Neuron. 1999;23:713-724.
25. Daimaru Y, Hashimoto H, Enjoji M. Malignant peripheral nervesheath tumors (malignant schwannomas). An immunohistochemical study of 29 cases. Am J Surg Pathol. 1985;9:434-444.
26. Weiss SW, Langloss JM, Enzinger FM. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest. 1983;49: 299-308.
27. Ramos-Herberth FI, Karamchandani J, Kim J, et al. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar. J Cutan Pathol. 2010;37:944-952.